Glycoprotein IIb/IIIa inhibitors improve outcomes in acute coronary syndromes
מתוך medicontext.co.il NEW YORK (Reuters Health) – Glycoprotein IIb/IIIa inhibitors reduce mortality and myocardial infarction (MI) in patients with acute coronary syndromes who would not
